Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment — Hangnyoung Choi (2024) | RDL Network
Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment
Article 2024 en
Authors
HC
Hangnyoung Choi
JK
Jae Han Kim
HY
Hee Sang Yang
Abstract
1 min read
Only risperidone, aripiprazole among pharmacological interventions, and parent training among non-pharmacological interventions can be recommended for irritability in ASD. As an augmentation to risperidone, several novel treatments show promising effects, but further RCTs are needed to replicate findings. Trial registration PROSPERO, CRD42021243965.
Jong Yeob Kim, Min Choi, Sungji Ha, Jimin Hwang, Ai Koyanagi, Elena Dragioti, Joaquim Raduà, Lee Smith, Louis Jacob, Gonzalo Salazar de Pablo, Seung Won Lee, Dong Keon Yon, Trevor Thompson, Samuele Cortese, Gianluca Lollo, Chih‐Sung Liang, Che‐Sheng Chu, Paolo Fusar‐Poli, Jae Il Shin, Marco Solmi
Ferrán Catalá-López, Brian Hutton, Amparo Núñez-Beltrán, Matthew J. Page, Manuel Ridao-López, Diego Macías Saint-Gerons, Miguel Catalá, Rafael Tabarés‐Seisdedos, David Moher
Discussion(0)
No comments yet. Be the first to comment.